global pharmaceutical packaging (Medical packaging) is market expected
GOOGLE Business and Social December 8 hearing in 2013, global pharmaceutical packaging market is expected to reach 62.3 billion U.S. dollars. 28% of the share of the United States continues to lead; China's strong growth is expected annual growth rate of 11.5%At present, the pharmaceutical industry has fully recognized the importance of good packaging design, as its role in helping the patient to comply with medication requirements to meet regulatory requirements, increasing the appeal of the brand's life and faced constant pressure. At the same time, pharmaceutical companies must innovate and improve efficiency to cope with the growing threat of counterfeit drugs. In addition, the pharmaceutical industry there is pressure, should pay attention to the green production methods, to shoulder a greater environmental responsibility. In this highly regulated industry, pharmaceutical packaging industry, where the direction of development? What are the opportunities? In order to this highly competitive market, successful, what obstacles need to be overcome?
In 2013, the size of global pharmaceutical packaging market is expected to reach 62.3 billion U.S. dollars, the United States will continue in this market dominant position, its share of global pharmaceutical packaging sales share of 28%. Globally, the Asia-Pacific region, the strongest growth rate, China would be to promote the region's largest pharmaceutical packaging industry growth, pushing hands, an annual growth rate is expected to 11.5%.
In developing countries to advance rapidly
"Global pharmaceutical packaging" research firm Freedonia Group, publisher of the report, analyst Bill Martineau said that the next few years, driven by a number of factors, developing countries will appear in the pharmaceutical packaging industry's highest growth rate. The most important factor is the use of low-cost generic drugs is becoming increasingly easy to use drug therapy to compensate for deficiencies in health care delivery system will also promote the growth of pharmaceutical packaging in these areas.
The development of global pharmaceutical packaging market will be high-value packaging systems with the gradual use be maintained, the higher these values reflected in the role of packaging systems: improving the patient's medication compliance; reduce the drugs are counterfeit and transfer risk; stop Drug Delivery risk of errors; for health care organizations to provide support to improve infection control standards; to distinguish it from other kinds of generic drugs provide the tools.
Martineau explained that the development of China's pharmaceutical packaging market will be subject to the domestic pharmaceutical industry, on par with the developed countries to gradually implement the GMP standard drivers, which will promote China's Pharmaceutical Packaging overall system upgrades. As for the rest of the world, India is expected to show strong growth, it is because India's patent pharmaceutical market and the generics market is expanding. In addition, the brand drug patent expired in succession, as well as expanding the use of generic drugs will also promote Brazil, Egypt, Hungary, Indonesia, Poland and South Korea's drug production, as well as the relevant pharmaceutical packaging needs.
Developed countries continue to lead
Although in the next five years, the pharmaceutical packaging market in developing countries is expected to expand significantly, but their development will not harm the interests of the developed countries. Thus, Western Europe, Japan and the United States will continue to occupy the global pharmaceutical packaging market, the vast majority of market share. In these three areas, pharmaceutical packaging market will focus on value-added packaging systems and new drug delivery carrier. Martineau forecasting, biotechnology, drug development will continue to promote the non-intestinal packaging (especially the small medicine bottle and pre-filled syringes) requirements.
The Government Pharmaceutical Packaging raise the standard (that is, requiring use of unit dose, high barrier and anti-counterfeiting packaging) will have an impact in Western Europe, and Japan because of its patented drugs and generic drug manufacturers broad, will continue to be medicinal container, cover plug and related accessories, and with a large diversity of consumer.
Increasingly popular prefilled
On drug research and drug delivery methods concerns the transfer, presumably for the production of prefilled inhalers, and prefilled syringe manufacturers offer exciting prospects for development. The primary packaging in the global market, these are two high-growth areas. Is expected to 2013, the market value of these two areas will reach 2.28 billion U.S. dollars and 33.7 billion U.S. dollars. Patients and changes in regulatory requirements, the new introduction of bio-engineering drugs, as well as to remain competitive will need to make these primary packaging market continues to expand their scale and help to achieve sustained growth. However, the plastic bottles will continue to occupy the largest market share, it is because of its low cost, with the versatility and usability, and quality and design is continuing to improve. Blister packaging, bagging and filling packets are also expected to increase with sales.
At the same time, the global pharmaceutical market will cover plugs and accessories 6.5% annual rate of growth in 2013 reached 24.1 billion U.S. dollars.
According to Freedonia Group research, this market growth was mainly driven by the following factors: anti-child-resistant, affinity for the elderly and the growing popularity of the drug Gaisse; to improve medication compliance in the use of prescription drug containers; labels enhanced visual effects ; anti-interference and security accessories.
Future market opportunities
Due to incessant reduce costs and improve efficiency to face the pressure, pharmaceutical packaging factory If you want to obtain a reasonable profit, we must change the overall business strategy. Martineau pointed out that the manufacturers should upgrade the level of packaging equipment to meet the high efficiency and small batch production. He also suggested that the use of contract packaging systems, enabling companies to expand their generic drug series of packaging products. Feasible, the pharmaceutical packaging companies also must remove any unnecessary secondary packaging. In addition, Martineau believed that medicine should enhance their packagers who provide services to the pharmaceutical companies applicability, especially in the packaging design, packaging equipment selection and installation, as well as contract packaging production.
According to Freedonia Grou data provided by approximately 2,000 companies worldwide production of pharmaceutical packaging products. Income for 2008 as measured by eight multinational companies supply nearly a quarter of the world's pharmaceutical packaging products, which are Rexam, MeadWestvaco, Gerresheimer, Becton Dickinson, Amcor, Catalent, West, and Alcan Corporation.
Who wish to maintain or increase its market share of the company, they must meet the needs of pharmaceutical packaging market trends. The next few years, pharmaceutical packaging market will be the biggest growth opportunity in the production areas: security-enhanced labeling and packaging components; for clinical trials and post-approval use of unit dose blister packaging; safety pin to improve and bring recyclable pre-filled syringes; unit dose medication prefilled inhalers; for liquid and paste drug medication Gaisse.
▲ According to Pharmaceutical Technology Europe (PTE) has done a survey, almost 50% of the respondents felt that the cost of the pharmaceutical packaging industry to carry out innovation activities in the biggest constraints; almost two-thirds of respondents felt that regulatory is a major obstacle to innovation.
▲ PTE conducted by another survey, 85% of respondents believed that the pharmaceutical industry needs to adopt more environmentally friendly packaging. (Di-)
